TY - JOUR
T1 - Pharmacological modulation of vascular ageing
T2 - A review from VascAgeNet
AU - Roth, Lynn
AU - Dogan, Soner
AU - Tuna, Bilge Guvenc
AU - Aranyi, Tamas
AU - Benitez, Sonia
AU - Borrell-Pages, Maria
AU - Bozaykut, Perinur
AU - De Meyer, Guido R.Y.
AU - Duca, Laurent
AU - Durmus, Nergiz
AU - Fonseca, Diogo
AU - Fraenkel, Emil
AU - Gillery, Philippe
AU - Giudici, Alessandro
AU - Jaisson, Stéphane
AU - Johansson, Madeleine
AU - Julve, Josep
AU - Lucas-Herald, Angela K.
AU - Martinet, Wim
AU - Maurice, Pascal
AU - McDonnell, Barry J.
AU - Ozbek, Emine Nur
AU - Pucci, Giacomo
AU - Pugh, Christopher J.A.
AU - Rochfort, Keith D.
AU - Roks, Anton J.M.
AU - Rotllan, Noemi
AU - Shadiow, James
AU - Sohrabi, Yahya
AU - Spronck, Bart
AU - Szeri, Flora
AU - Terentes-Printzios, Dimitrios
AU - Tunc Aydin, Elif
AU - Tura-Ceide, Olga
AU - Ucar, Eda
AU - Yetik-Anacak, Gunay
N1 - Publisher Copyright:
© 2023 The Authors
PY - 2023/11/25
Y1 - 2023/11/25
N2 - Vascular ageing, characterized by structural and functional changes in blood vessels of which arterial stiffness and endothelial dysfunction are key components, is associated with increased risk of cardiovascular and other age-related diseases. As the global population continues to age, understanding the underlying mechanisms and developing effective therapeutic interventions to mitigate vascular ageing becomes crucial for improving cardiovascular health outcomes. Therefore, this review provides an overview of the current knowledge on pharmacological modulation of vascular ageing, highlighting key strategies and promising therapeutic targets. Several molecular pathways have been identified as central players in vascular ageing, including oxidative stress and inflammation, the renin-angiotensin-aldosterone system, cellular senescence, macroautophagy, extracellular matrix remodelling, calcification, and gasotransmitter-related signalling. Pharmacological and dietary interventions targeting these pathways have shown potential in ameliorating age-related vascular changes. Nevertheless, the development and application of drugs targeting vascular ageing is complicated by various inherent challenges and limitations, such as certain preclinical methodological considerations, interactions with exercise training and sex/gender-related differences, which should be taken into account. Overall, pharmacological modulation of endothelial dysfunction and arterial stiffness as hallmarks of vascular ageing, holds great promise for improving cardiovascular health in the ageing population. Nonetheless, further research is needed to fully elucidate the underlying mechanisms and optimize the efficacy and safety of these interventions for clinical translation.
AB - Vascular ageing, characterized by structural and functional changes in blood vessels of which arterial stiffness and endothelial dysfunction are key components, is associated with increased risk of cardiovascular and other age-related diseases. As the global population continues to age, understanding the underlying mechanisms and developing effective therapeutic interventions to mitigate vascular ageing becomes crucial for improving cardiovascular health outcomes. Therefore, this review provides an overview of the current knowledge on pharmacological modulation of vascular ageing, highlighting key strategies and promising therapeutic targets. Several molecular pathways have been identified as central players in vascular ageing, including oxidative stress and inflammation, the renin-angiotensin-aldosterone system, cellular senescence, macroautophagy, extracellular matrix remodelling, calcification, and gasotransmitter-related signalling. Pharmacological and dietary interventions targeting these pathways have shown potential in ameliorating age-related vascular changes. Nevertheless, the development and application of drugs targeting vascular ageing is complicated by various inherent challenges and limitations, such as certain preclinical methodological considerations, interactions with exercise training and sex/gender-related differences, which should be taken into account. Overall, pharmacological modulation of endothelial dysfunction and arterial stiffness as hallmarks of vascular ageing, holds great promise for improving cardiovascular health in the ageing population. Nonetheless, further research is needed to fully elucidate the underlying mechanisms and optimize the efficacy and safety of these interventions for clinical translation.
KW - Arterial stiffness
KW - Dietary supplements
KW - Drugs
KW - Endothelial dysfunction
KW - Pharmacology
KW - Vascular ageing
UR - http://www.scopus.com/inward/record.url?scp=85177763196&partnerID=8YFLogxK
U2 - 10.1016/j.arr.2023.102122
DO - 10.1016/j.arr.2023.102122
M3 - Review article
C2 - 37956927
AN - SCOPUS:85177763196
SN - 1568-1637
VL - 92
JO - Ageing Research Reviews
JF - Ageing Research Reviews
M1 - 102122
ER -